DR. MITCHELL S KARL, MD
Osteopathic Medicine at 13 St, Boca Raton, FL
License number
Florida ME50027
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
880 NW 13Th St STE 1B, Boca Raton, FL 33486
Phone
(561) 392-9214
(561) 394-4250 (Fax)
(561) 394-4250 (Fax)
Personal information
See more information about MITCHELL S KARL at radaris.comName
Address
Phone
3075 NW 60Th St, Boca Raton, FL 33496
3075 60Th St, Boca Raton, FL 33496
880 13Th St, Boca Raton, FL 33486
339 Sunset Bay Ln, West Palm Beach, FL 33418
Organization information
See more information about MITCHELL S KARL at bizstanding.comMitchell S Karl MD PA
880 NW 13 St, Boca Raton, FL 33486
Industry:
Cardiologist
Phone:
(561) 392-9214 (Phone)
Office Managers:
Mitchell S. Karl (Owner, Cardiovascular, Medical Doctor),Mona G. Fisher (Office Manager)
Holy Cross Medical Group - Mitchell S Karl MD
880 NW 13 St STE 1B, Boca Raton, FL 33486
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Phone:
(561) 392-9214 (Phone)
Professional information
Mitchell S Karl, Boca Raton FL
Specialties:
Cardiologist
Address:
880 Nw 13Th St, Boca Raton, FL 33486
Education:
State University of New York Downstate Medical Center, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Prepackaged Aqueous Pharmaceutical Formulation For The Treatment Of Cardiac Conditions Containing At Least Two Different Active Agents And Method Of Formulation
US Patent:
2004022, Nov 18, 2004
Filed:
Feb 23, 2004
Appl. No.:
10/785169
Inventors:
Mitchell Karl - Boca Raton FL, US
International Classification:
A61K031/517, A61K009/00
US Classification:
424/400000
Abstract:
Prepackaged aqueous pharmaceutical compositions for the treatment of cardiac conditions are disclosed including at least two different pharmacologically active agents for the treatment of a cardiac condition, a buffering agent to buffer the composition, and an osmotic-adjusting agent. Additionally, a method of forming a prepackaged aqueous pharmaceutical composition for the treatment of cardiac conditions is disclosed, the method including the steps of mixing at least two different pharmacologically active agents, adding a buffering agent to the mixed at least two different pharmacologically active agents, and adding an osmotic-adjusting agent to the mixed at least two different pharmacologically active agents.
Pharmaceutical Formulation Delivery System
US Patent:
2006017, Aug 3, 2006
Filed:
Mar 1, 2006
Appl. No.:
11/365563
Inventors:
Mitchell Karl - Boca Raton FL, US
International Classification:
A61K 9/00, B65D 83/04
US Classification:
424400000, 206531000
Abstract:
The invention relates to the development of a simple and inexpensive oral delivery system for customized pharmaceutical formulations for treating patients having conditions such as HIV/AIDS, cancer, and heart disease. The system includes a) a plurality of prepackaged pharmaceutical formulations containing at least two pharmacologically active ingredients in periodic (e.g., daily, twice-daily, three times a day, four times a day) dosage amounts for treating a plurality of patients having differing characteristics and particular conditions to be treated, each formulation differing in pharmacologically active ingredients and/or dosage amounts from each other, and b) a chart listing the plurality of formulations for assisting a physician in deciding which formulation to administer to a patient suffering from a particular condition based on the patient's characteristics. A customized pharmaceutical formulation that is suitable for a patient having a particular condition to be treated is easily selected by the physician from a paper or electronic chart listing a plurality of different pharmaceutical formulations and correlating the different formulations to different patient characteristics that should be considered before administering a pharmaceutical formulation to the patient.
Prepackaged Aqueous Pharmaceutical Formulations
US Patent:
2005027, Dec 8, 2005
Filed:
Jun 6, 2005
Appl. No.:
11/145666
Inventors:
Mitchell Karl - Boca Raton FL, US
International Classification:
A61K031/56, A61K009/00
US Classification:
424400000
Abstract:
Prepackaged aqueous pharmaceutical compositions for the treatment of a condition are disclosed including at least two different pharmacologically active agents for the treatment of the condition, a buffering agent to buffer the composition, and an osmotic-adjusting agent. Additionally, a method of forming a prepackaged aqueous pharmaceutical composition for the treatment of a condition is disclosed, the method including the steps of mixing at least two different pharmacologically active agents, adding a buffering agent to the mixed at least two different pharmacologically active agents, and adding an osmotic-adjusting agent to the mixed at least two different pharmacologically active agents.
Nutritional Supplement
US Patent:
2010031, Dec 16, 2010
Filed:
Aug 24, 2010
Appl. No.:
12/861898
Inventors:
Mitchell Karl - Boca Raton FL, US
International Classification:
A23L 1/105, A23L 2/00, A23L 2/02
US Classification:
426 2, 426531, 426590, 426599, 426618, 426658
Abstract:
A nutritional supplement specifically designed to lower cholesterol that addresses multiple mechanisms including hepatic synthesis and release, intestinal absorption of cholesterol, while, at the same time, including ingredients that mitigate the side effects of the constituents and increase their efficacy by affecting emotional factors that influence compliance such as a sense of well-being and euphoria on the one hand, or an increased overall metabolism and desire for the product stemming from its coloration on the other hand. The nutritional supplement can be prepared as a powder that can be added to a food item by a human subject, a concentrate that can be mixed with water or another beverage, or incorporated into a baked good for ingestion by the human subject.
Nutritional Drink
US Patent:
2008030, Dec 11, 2008
Filed:
May 15, 2008
Appl. No.:
12/120765
Inventors:
Mitchell Karl - Boca Raton FL, US
International Classification:
A61K 31/122, A61K 36/06, A61K 31/205, A61K 31/375, A61K 31/455, A61K 36/00, A61P 3/06, A61P 9/10
US Classification:
424 941, 42419516, 424725, 514556, 514474, 514356
Abstract:
A first composition of drink ingredients specifically designed to lower cholesterol that addresses multiple mechanisms including hepatic synthesis and release, intestinal absorption of cholesterol, while, at the same time, including ingredients that mitigate the side effects of the constituents and increase their efficacy by affecting emotional factors that influence compliance such as a sense of well-being and euphoria on the one hand, or an increased overall metabolism and desire for the product stemming from its coloration on the other hand.
Nutritional Drink
US Patent:
2010002, Jan 28, 2010
Filed:
Oct 8, 2009
Appl. No.:
12/576035
Inventors:
Mitchell Karl - Boca Raton FL, US
International Classification:
A61K 36/899, A61P 7/00
US Classification:
424750
Abstract:
A first composition of drink ingredients specifically designed to lower cholesterol that addresses multiple mechanisms including hepatic synthesis and release, intestinal absorption of cholesterol, while, at the same time, including ingredients that mitigate the side effects of the constituents and increase their efficacy by affecting emotional factors that influence compliance such as a sense of well-being and euphoria on the one hand, or an increased overall metabolism and desire for the product stemming from its coloration on the other hand.